Go to main content
Harvard Business School
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions

Faculty & Research

  • HOME
  • FACULTY
  • RESEARCH
    • Global Research Centers
    • HBS Case Collection
    • HBS Case Development
    • Initiatives & Projects
    • Publications
    • Research Associate (RA) Positions
    • Research Services
    • Seminars & Conferences
    Close
  • FEATURED TOPICS
    • Business and Environment
    • Business History
    • Entrepreneurship
    • Finance
    • Globalization
    • Health Care
    • Human Behavior and Decision-Making
    • Leadership
    • Social Enterprise
    • Technology and Innovation
    Close
  • ACADEMIC UNITS
    • Accounting and Management
    • Business, Government and the International Economy
    • Entrepreneurial Management
    • Finance
    • General Management
    • Marketing
    • Negotiation, Organizations & Markets
    • Organizational Behavior
    • Strategy
    • Technology and Operations Management
    Close

Case | HBS Case Collection | March 2018 (Revised September 2018)

Gene Lee Navigates the Darden Takeover

by Joshua D. Margolis, H. Lawrence Culp, James Barnett and Aldo Sesia

  • Print
  • Email

Abstract

Following a full takeover of Darden Restaurant’s Board of Directors, Darden COO Gene Lee is weighing an offer to become interim CEO.

Keywords: shareholder activism; Investment Activism; Crisis Management; Personal Development and Career; Decision Choices and Conditions; Food and Beverage Industry; United States;

Language: English Format: Print 18 pages Educators

Citation:

Margolis, Joshua D., H. Lawrence Culp, James Barnett, and Aldo Sesia. "Gene Lee Navigates the Darden Takeover." Harvard Business School Case 418-015, March 2018. (Revised September 2018.)

Related Work

  1. Case | HBS Case Collection | March 2018 (Revised September 2018)

    Gene Lee Navigates the Darden Takeover

    Joshua D. Margolis, H. Lawrence Culp, James Barnett and Aldo Sesia

    Following a full takeover of Darden Restaurant’s Board of Directors, Darden COO Gene Lee is weighing an offer to become interim CEO.

    Keywords: shareholder activism; Investment Activism; Crisis Management; Personal Development and Career; Decision Choices and Conditions; Food and Beverage Industry; United States;

    Citation:

    Margolis, Joshua D., H. Lawrence Culp, James Barnett, and Aldo Sesia. "Gene Lee Navigates the Darden Takeover." Harvard Business School Case 418-015, March 2018. (Revised September 2018.)  View Details
    CiteView DetailsEducators Related

About the Author

Photo
Joshua D. Margolis
James Dinan and Elizabeth Miller Professor of Business Administration
Unit Head, Organizational Behavior
Chair, Program for Leadership Development
Organizational Behavior

View Profile »
View Publications »

 

More from the Author

  • Case | HBS Case Collection | January 2019 (Revised January 2019)

    An eSports Profile: Team Liquid & aXiomatic

    Robert F. Higgins and James Barnett

    Citation:

    Higgins, Robert F., and James Barnett. "An eSports Profile: Team Liquid & aXiomatic." Harvard Business School Case 819-076, January 2019. (Revised January 2019.)  View Details
    CiteView DetailsEducators Related
  • Technical Note | HBS Case Collection | December 2018

    Note on Economic Inequality (2018)

    Rebecca Henderson, Clayton S. Rose, Jessica A. Gover and Aldo Sesia

    For over half a century, most of the world's economies have enjoyed steady growth and prosperity. While this economic growth has reduced the number of people living in poverty, it has come with an increase in economic inequality. The gap between the "haves" and the "have-nots" in developed countries has widened, with a small proportion of the population reaping an increasingly larger share of a country's economic rewards. This growing economic inequality has been particularly pronounced in the United States, but the phenomenon has also occurred in many nations. This note provides background on aspects of economic inequality. It begins by describing both income inequality and wealth inequality, providing an explanation of two widely used metrics and data that show increasing inequalities over time. It then moves to the factors that might contribute to this inequality, as well to propositions of economic and social consequences that might result from the widening gap. Finally, it addresses the issue of "equality of opportunity" or social mobility. This is an update to the Note on Economic Inequality (2015). It provides additional information on economic inequality, including union membership and inequality and political polarization.

    Keywords: Economic inequalty; wealth inequality; equality of opportunity; political polarization; Economic Growth; Economics; Equality and Inequality; Society; Problems and Challenges;

    Citation:

    Henderson, Rebecca, Clayton S. Rose, Jessica A. Gover, and Aldo Sesia. "Note on Economic Inequality (2018)." Harvard Business School Technical Note 319-071, December 2018.  View Details
    CiteView DetailsEducators Related
  • Case | HBS Case Collection | November 2018

    David Hysong and SHEPHERD Therapeutics

    Ananth Raman, John Masko and Aldo Sesia

    In 2016, David Hysong, at age 27, found out he had a rare, incurable cancer. Rather than wait around to die, Hysong, a recent graduate of Harvard Divinity School, decided to launch a biotechnology company called Shepherd Therapeutics to development treatments for his’ and other rare cancers. Two years later, the company had several drugs in promising stages of development but were at least 3 to 5 years away from commercialization, if they made it through clinical trials successfully. Only about 4% of drugs that enter clinical trials receive U.S. FDA approval. It is October 2018, and Shepherd is running out of money. Hysong needs to raise $5 million to fund operations for 2019 and at least $20 million for the following few years. But the company is too early to attract the type of venture capital he needs. Even if he got financing, Hysong worried that the company’s mission could be compromised by investors more interested in a return on their investment than saving lives, and he worried about the scaling challenges ahead.

    Keywords: cancer; therapeutics; drugs; Health Care and Treatment; Business Startups; Product Development; Financing and Loans; Growth and Development Strategy; Problems and Challenges;

    Citation:

    Raman, Ananth, John Masko, and Aldo Sesia. "David Hysong and SHEPHERD Therapeutics." Harvard Business School Case 619-012, November 2018.  View Details
    CiteView DetailsEducators Related
ǁ
Campus Map
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→ Map & Directions
→ More Contact Information
→ More Contact Information
→ More Contact Information
→ More Contact Information
  • HBS Facebook
  • Alumni Facebook
  • Executive Education Facebook
  • Michael Porter Facebook
  • Working Knowledge Facebook
  • HBS Twitter
  • Executive Education Twitter
  • HBS Alumni Twitter
  • Michael Porter Twitter
  • Recruiting Twitter
  • Rock Center Twitter
  • Working Knowledge Twitter
  • Jobs Twitter
  • HBS Youtube
  • Michael Porter Youtube
  • Executive Education Youtube
  • HBS Linkedin
  • Alumni Linkedin
  • Executive Education Linkedin
  • MBA Linkedin
  • Linkedin
  • HBS Instagram
  • Alumni Instagram
  • Executive Education Instagram
  • Michael Porter Instagram
  • HBS iTunes
  • Executive Education iTunes
  • HBS Tumblr
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Privacy
  • Terms of Use
Copyright © President & Fellows of Harvard College